Galapagos fundamental analysis

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:4em;padding-top: 25px;;'>GA</div>
GLPG -- USA Stock  

Earning Report: April 3, 2020  

The Drivers Module shows relationships between Galapagos's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Galapagos NV over time as well as its relative position and ranking within its peers. Please check Risk vs Return Analysis

Galapagos NV Total Debt vs. Current Liabilities Fundamental Analysis

Galapagos NV is one of the top stocks in current liabilities category among related companies. It is rated below average in total debt category among related companies . The ratio of Current Liabilities to Total Debt for Galapagos NV is about  636.17 
Current Liabilities is company's short term debts. This usually includes obligations that are due within next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Liabilities 
Accrued Debt 
143.72 M
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principle payments will eventually prevent the firm from borrow excessively.
Total Debt 
225.92 K
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
Galapagos NV is rated below average in total debt category among related companies. Total debt of Biotechnology industry is currently estimated at about 330.4 Million. Galapagos adds roughly 225,921 in total debt claiming only tiny portion of stocks in Biotechnology industry.
Total debt  Capitalization  Workforce  Revenue  Valuation

Galapagos Fundamental Comparison